Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gynecologic Surgical Procedures | 4 | 2022 | 70 | 1.840 |
Why?
|
| Pelvic Floor Disorders | 4 | 2022 | 8 | 1.390 |
Why?
|
| Pelvic Organ Prolapse | 6 | 2023 | 27 | 1.290 |
Why?
|
| Obstetric Labor Complications | 3 | 2024 | 96 | 1.220 |
Why?
|
| Lacerations | 2 | 2019 | 34 | 1.210 |
Why?
|
| Anal Canal | 3 | 2019 | 79 | 0.940 |
Why?
|
| Delivery, Obstetric | 4 | 2024 | 253 | 0.930 |
Why?
|
| Vagina | 6 | 2023 | 199 | 0.920 |
Why?
|
| Laparoscopy | 4 | 2022 | 499 | 0.760 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 197 | 0.730 |
Why?
|
| Simulation Training | 1 | 2022 | 139 | 0.670 |
Why?
|
| Dilatation | 2 | 2024 | 68 | 0.650 |
Why?
|
| Documentation | 1 | 2019 | 115 | 0.600 |
Why?
|
| Pregnancy Complications | 2 | 2010 | 502 | 0.470 |
Why?
|
| Quality Improvement | 1 | 2019 | 619 | 0.430 |
Why?
|
| Pelvic Floor | 3 | 2024 | 34 | 0.420 |
Why?
|
| Emotional Intelligence | 1 | 2012 | 13 | 0.410 |
Why?
|
| Achievement | 1 | 2012 | 32 | 0.410 |
Why?
|
| Labor Pain | 1 | 2012 | 3 | 0.410 |
Why?
|
| Analgesia, Epidural | 1 | 2012 | 27 | 0.400 |
Why?
|
| Valsalva Maneuver | 1 | 2011 | 10 | 0.390 |
Why?
|
| Labor, Obstetric | 1 | 2012 | 95 | 0.380 |
Why?
|
| Patient Admission | 1 | 2012 | 183 | 0.370 |
Why?
|
| Cardiotocography | 1 | 2010 | 19 | 0.350 |
Why?
|
| Gynecology | 3 | 2024 | 125 | 0.340 |
Why?
|
| Obstetrics | 3 | 2024 | 232 | 0.340 |
Why?
|
| Intraoperative Care | 1 | 2010 | 101 | 0.340 |
Why?
|
| Computer Simulation | 2 | 2022 | 606 | 0.330 |
Why?
|
| Abdomen, Acute | 1 | 2008 | 13 | 0.320 |
Why?
|
| Pregnancy | 9 | 2024 | 7082 | 0.320 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 439 | 0.320 |
Why?
|
| Female | 28 | 2024 | 64626 | 0.310 |
Why?
|
| Parturition | 2 | 2018 | 62 | 0.290 |
Why?
|
| Endometrial Hyperplasia | 1 | 2005 | 18 | 0.250 |
Why?
|
| Salpingectomy | 2 | 2016 | 16 | 0.240 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 88 | 0.240 |
Why?
|
| Adult | 17 | 2024 | 28681 | 0.240 |
Why?
|
| Humans | 35 | 2024 | 121933 | 0.240 |
Why?
|
| Prospective Studies | 7 | 2022 | 5912 | 0.230 |
Why?
|
| Supreme Court Decisions | 1 | 2024 | 14 | 0.230 |
Why?
|
| Endometrial Neoplasms | 1 | 2005 | 99 | 0.230 |
Why?
|
| Hysterectomy | 3 | 2023 | 182 | 0.220 |
Why?
|
| Menopause | 1 | 2023 | 73 | 0.220 |
Why?
|
| Hyaluronic Acid | 1 | 2023 | 96 | 0.210 |
Why?
|
| Suture Techniques | 3 | 2019 | 199 | 0.200 |
Why?
|
| Surgical Mesh | 1 | 2022 | 61 | 0.200 |
Why?
|
| Urinary Incontinence | 1 | 2022 | 69 | 0.200 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 788 | 0.190 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 865 | 0.190 |
Why?
|
| Urinary Retention | 1 | 2021 | 17 | 0.190 |
Why?
|
| Internship and Residency | 3 | 2024 | 1150 | 0.180 |
Why?
|
| Medicare | 1 | 2023 | 417 | 0.170 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 403 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1032 | 0.160 |
Why?
|
| Sperm Count | 2 | 1998 | 75 | 0.160 |
Why?
|
| Hospitals, Private | 1 | 2019 | 18 | 0.160 |
Why?
|
| Motor Neurons | 1 | 2019 | 138 | 0.160 |
Why?
|
| Safety-net Providers | 1 | 2019 | 41 | 0.160 |
Why?
|
| Colectomy | 1 | 2019 | 75 | 0.150 |
Why?
|
| Rupture | 1 | 2018 | 32 | 0.150 |
Why?
|
| Ileum | 1 | 2019 | 134 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2024 | 1361 | 0.150 |
Why?
|
| Rectum | 1 | 2019 | 97 | 0.150 |
Why?
|
| Labor Stage, First | 1 | 2017 | 7 | 0.150 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 3623 | 0.150 |
Why?
|
| Elasticity | 1 | 2018 | 92 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 252 | 0.150 |
Why?
|
| Constipation | 1 | 2019 | 113 | 0.150 |
Why?
|
| Perineum | 1 | 2018 | 48 | 0.150 |
Why?
|
| Action Potentials | 1 | 2019 | 499 | 0.130 |
Why?
|
| Ovariectomy | 1 | 2016 | 180 | 0.130 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 581 | 0.130 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2016 | 28 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2018 | 729 | 0.120 |
Why?
|
| Middle Aged | 10 | 2021 | 25447 | 0.120 |
Why?
|
| Mothers | 1 | 2018 | 346 | 0.120 |
Why?
|
| Young Adult | 3 | 2024 | 8750 | 0.120 |
Why?
|
| Suburethral Slings | 1 | 2014 | 6 | 0.120 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2014 | 30 | 0.110 |
Why?
|
| Urethra | 1 | 2014 | 81 | 0.110 |
Why?
|
| Quality of Life | 1 | 2023 | 1900 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2024 | 937 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2023 | 15630 | 0.110 |
Why?
|
| Organization and Administration | 1 | 2012 | 4 | 0.110 |
Why?
|
| Models, Biological | 1 | 2017 | 1435 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 413 | 0.100 |
Why?
|
| Aging | 1 | 2019 | 1160 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2019 | 689 | 0.100 |
Why?
|
| Cultural Characteristics | 1 | 2012 | 40 | 0.100 |
Why?
|
| Acculturation | 1 | 2012 | 68 | 0.100 |
Why?
|
| Cultural Competency | 1 | 2012 | 52 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2022 | 11702 | 0.090 |
Why?
|
| Aged | 7 | 2023 | 18505 | 0.090 |
Why?
|
| Vulvar Diseases | 1 | 2010 | 11 | 0.090 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2000 | 53 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3289 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 293 | 0.080 |
Why?
|
| Prenatal Care | 1 | 2012 | 340 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 42 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 349 | 0.080 |
Why?
|
| Biliary Tract Diseases | 1 | 2008 | 35 | 0.080 |
Why?
|
| Abscess | 1 | 2010 | 138 | 0.080 |
Why?
|
| Piperazines | 2 | 2000 | 227 | 0.080 |
Why?
|
| Safety | 1 | 2008 | 217 | 0.070 |
Why?
|
| Erectile Dysfunction | 2 | 2000 | 170 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2008 | 130 | 0.070 |
Why?
|
| Appendicitis | 1 | 2008 | 129 | 0.070 |
Why?
|
| Internet | 1 | 2010 | 373 | 0.070 |
Why?
|
| United States | 3 | 2024 | 10434 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 158 | 0.060 |
Why?
|
| Parity | 1 | 2024 | 79 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1082 | 0.060 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2023 | 14 | 0.060 |
Why?
|
| Accreditation | 1 | 2024 | 83 | 0.060 |
Why?
|
| Dehydroepiandrosterone | 1 | 2023 | 17 | 0.060 |
Why?
|
| Women's Health | 1 | 2024 | 129 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2024 | 970 | 0.050 |
Why?
|
| Prolapse | 1 | 2022 | 11 | 0.050 |
Why?
|
| Endometrium | 1 | 2005 | 274 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 161 | 0.050 |
Why?
|
| Time Factors | 1 | 2011 | 5997 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1711 | 0.050 |
Why?
|
| Private Sector | 1 | 2021 | 24 | 0.050 |
Why?
|
| Hospitals, Public | 1 | 2021 | 38 | 0.050 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 49 | 0.050 |
Why?
|
| Adolescent | 1 | 2019 | 18941 | 0.050 |
Why?
|
| Estrogens | 1 | 2023 | 506 | 0.050 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2021 | 70 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2021 | 73 | 0.040 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2000 | 34 | 0.040 |
Why?
|
| Urology | 1 | 2021 | 73 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 328 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 505 | 0.040 |
Why?
|
| Defecography | 1 | 2019 | 2 | 0.040 |
Why?
|
| Psychometrics | 1 | 2023 | 666 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 2019 | 21 | 0.040 |
Why?
|
| Electromyography | 1 | 2019 | 161 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 2000 | 166 | 0.040 |
Why?
|
| Oligospermia | 1 | 1998 | 57 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2019 | 185 | 0.040 |
Why?
|
| Vasovasostomy | 1 | 1998 | 23 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 228 | 0.040 |
Why?
|
| Testosterone | 1 | 2023 | 459 | 0.040 |
Why?
|
| Epididymis | 1 | 1998 | 54 | 0.040 |
Why?
|
| Sacrum | 1 | 2018 | 29 | 0.040 |
Why?
|
| Viscosity | 1 | 2018 | 35 | 0.040 |
Why?
|
| Geography | 1 | 1998 | 112 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 166 | 0.040 |
Why?
|
| Microsurgery | 1 | 1998 | 69 | 0.040 |
Why?
|
| Prostatectomy | 1 | 1999 | 333 | 0.040 |
Why?
|
| Testis | 1 | 2000 | 407 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1526 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2000 | 262 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2000 | 301 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 604 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 34 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2793 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 815 | 0.030 |
Why?
|
| Male | 8 | 2024 | 59266 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1146 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 923 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 650 | 0.030 |
Why?
|
| Texas | 1 | 2021 | 3526 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2014 | 446 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1980 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2022 | 2871 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 1226 | 0.020 |
Why?
|
| Sildenafil Citrate | 2 | 2000 | 50 | 0.020 |
Why?
|
| Sulfones | 2 | 2000 | 66 | 0.020 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2010 | 25 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2771 | 0.020 |
Why?
|
| Purines | 2 | 2000 | 107 | 0.020 |
Why?
|
| Cellulitis | 1 | 2010 | 64 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2010 | 196 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 220 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6103 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 3223 | 0.020 |
Why?
|
| Reoperation | 1 | 2010 | 771 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 550 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 1251 | 0.010 |
Why?
|
| Flushing | 1 | 2000 | 5 | 0.010 |
Why?
|
| Ejaculation | 1 | 2000 | 20 | 0.010 |
Why?
|
| Dizziness | 1 | 2000 | 27 | 0.010 |
Why?
|
| Nose | 1 | 2000 | 93 | 0.010 |
Why?
|
| Headache | 1 | 2000 | 107 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2000 | 137 | 0.010 |
Why?
|
| Dyspepsia | 1 | 2000 | 101 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 2000 | 123 | 0.010 |
Why?
|
| Testicular Diseases | 1 | 1998 | 11 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2381 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2000 | 231 | 0.010 |
Why?
|
| Biopsy | 1 | 2000 | 1244 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 9686 | 0.010 |
Why?
|
| Logistic Models | 1 | 2000 | 1759 | 0.010 |
Why?
|
| Incidence | 1 | 2000 | 2997 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 4990 | 0.010 |
Why?
|
| Prognosis | 1 | 1998 | 4485 | 0.010 |
Why?
|